Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Blanca Osorio

Psychiatry Natchitoches, LA Medical Doctor

NPI 1962566166 CMS profile 732833

105 Jefferson St, Natchitoches, LA 71457

Open in the dashboard

General payments

$2,945

188 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Blanca Osorio of Natchitoches, LA is reported in the CMS Open Payments database as having received $2,945 across 188 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $135 8
2020 General $1,357 98
2019 General $1,453 82

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Blanca Osorio
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Blanca Osorio were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Blanca Osorio Psychiatry median Middle half National median
2019 $1,453 $184 $59–$605 $163
2020 $1,357 $119 $36–$372 $114
2021 $135 $143 $43–$576 $132
2022 $0 $153 $50–$590 $149
2023 $0 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. Otsuka America Pharmaceutical, Inc. $497 32 payments
  2. Sunovion Pharmaceuticals Inc. $416 26 payments
  3. Lundbeck LLC $359 26 payments
  4. Allergan Inc. $300 29 payments
  5. Vanda Pharmaceuticals Inc. $287 14 payments
  6. Alkermes, Inc. $268 18 payments
  7. Neurocrine Biosciences, Inc. $221 6 payments
  8. Teva Pharmaceuticals USA, Inc. $138 9 payments
  9. Janssen Pharmaceuticals, Inc $118 7 payments
  10. Takeda Pharmaceuticals U.S.A., Inc. $92 6 payments
  11. Other $249 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Food and Beverage $2,932 186 payments
  2. Education $13 2 payments
Products named General payments · program years 2019–2021
  1. LATUDA $416 26 payments
  2. ABILIFY MAINTENA $310 17 payments
  3. VRAYLAR $297 28 payments
  4. HETLIOZ $287 14 payments
  5. FANAPT $287 14 payments
  6. REXULTI $276 20 payments
  7. ARISTADA INITIO $268 18 payments
  8. ARISTADA Cns $268 18 payments
  9. ARISTADA Cns $268 18 payments
  10. ARISTADA Cns $268 18 payments
  11. Other $1,441 88 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

496

Median for Psychiatry: 574

Drug cost

$7,451

Median for Psychiatry: $27,624

Branded share of claims

7.5%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Aripiprazole Generic 59 $2,495
Trazodone Hcl Generic 49 $783
Buspirone Hcl Generic 62 $681
Haloperidol Generic 14 $524
Hydroxyzine Hcl Generic 40 $402
Quetiapine Fumarate Generic 32 $377
Duloxetine Hcl Generic 35 $351
Benztropine Mesylate Generic 34 $336
Risperidone Generic 32 $331
Olanzapine Generic 27 $292

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Records

188 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record